https://www.selleckchem.com/products/mek162.html
Only a few individuals within this cohort group present with exclusive eye disease ( less then 5%), and the rate of secondary ocular involvement is only 5-9%. In PCNSL cohorts defined by the involvement of the ocular compartment, with or without non-ocular CNS involvement (termed 'VRL ± non-ocular CNS involvement' cohorts), 58% of persons have a primary ocular diagnosis, which carries a 50% risk of secondary involvement in the CNS beyond the eye. Rates of non-ocular CNS involvement with VRL at diagnosis or over the course of disease are